 Rachel McMahan
Concepts (278)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 9 | 2025 | 328 | 1.850 |
Why?
| | Gastrointestinal Microbiome | 6 | 2025 | 698 | 1.440 |
Why?
| | Ethanol | 9 | 2024 | 613 | 1.150 |
Why?
| | Dysbiosis | 5 | 2025 | 181 | 1.150 |
Why?
| | Inflammation | 10 | 2025 | 2831 | 0.960 |
Why?
| | Pneumonia | 4 | 2025 | 633 | 0.950 |
Why?
| | Feces | 3 | 2025 | 479 | 0.940 |
Why?
| | Intestines | 3 | 2022 | 354 | 0.870 |
Why?
| | Alcohol Drinking | 5 | 2025 | 813 | 0.850 |
Why?
| | Public Opinion | 2 | 2023 | 66 | 0.830 |
Why?
| | Hepacivirus | 5 | 2017 | 260 | 0.580 |
Why?
| | Receptors, Antigen, T-Cell | 6 | 2017 | 716 | 0.580 |
Why?
| | Non-alcoholic Fatty Liver Disease | 5 | 2020 | 278 | 0.550 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2024 | 604 | 0.540 |
Why?
| | Liver | 7 | 2024 | 1867 | 0.530 |
Why?
| | Alcoholism | 5 | 2024 | 796 | 0.500 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2016 | 206 | 0.460 |
Why?
| | Mice | 27 | 2025 | 17705 | 0.440 |
Why?
| | T-Lymphocytes | 7 | 2017 | 1975 | 0.430 |
Why?
| | Mice, Inbred C57BL | 14 | 2025 | 5733 | 0.420 |
Why?
| | Fatty Liver | 2 | 2013 | 242 | 0.420 |
Why?
| | T-Lymphocytes, Cytotoxic | 2 | 2010 | 171 | 0.390 |
Why?
| | Macrophages | 8 | 2024 | 1540 | 0.370 |
Why?
| | Hepatitis C, Chronic | 2 | 2011 | 164 | 0.370 |
Why?
| | Alcoholic Intoxication | 2 | 2023 | 69 | 0.370 |
Why?
| | Cancer Vaccines | 3 | 2010 | 164 | 0.360 |
Why?
| | Animals | 32 | 2025 | 36882 | 0.360 |
Why?
| | Monocytes | 3 | 2013 | 562 | 0.360 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2016 | 182 | 0.360 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 220 | 0.350 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2010 | 184 | 0.320 |
Why?
| | Age Factors | 4 | 2025 | 3258 | 0.300 |
Why?
| | Cytokines | 5 | 2025 | 2070 | 0.290 |
Why?
| | Disease Models, Animal | 10 | 2025 | 4276 | 0.290 |
Why?
| | Major Histocompatibility Complex | 3 | 2017 | 230 | 0.290 |
Why?
| | Lymphocyte Activation | 4 | 2007 | 1134 | 0.280 |
Why?
| | Antigens, CD | 1 | 2010 | 527 | 0.270 |
Why?
| | Permeability | 3 | 2022 | 161 | 0.270 |
Why?
| | Glycerophospholipids | 2 | 2025 | 34 | 0.270 |
Why?
| | Macrophages, Alveolar | 3 | 2022 | 392 | 0.270 |
Why?
| | Myelin Basic Protein | 2 | 2003 | 47 | 0.250 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2024 | 365 | 0.240 |
Why?
| | Calgranulin A | 1 | 2025 | 11 | 0.240 |
Why?
| | Membrane Proteins | 2 | 2013 | 1151 | 0.230 |
Why?
| | Kupffer Cells | 2 | 2019 | 49 | 0.230 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2025 | 81 | 0.230 |
Why?
| | Immunity, Innate | 2 | 2024 | 819 | 0.230 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2025 | 71 | 0.230 |
Why?
| | Azepines | 1 | 2024 | 97 | 0.220 |
Why?
| | Immunity | 1 | 2025 | 139 | 0.220 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2024 | 55 | 0.210 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2024 | 135 | 0.210 |
Why?
| | Diet, Western | 1 | 2024 | 81 | 0.210 |
Why?
| | Triazoles | 1 | 2024 | 150 | 0.210 |
Why?
| | Graft Rejection | 1 | 2007 | 571 | 0.200 |
Why?
| | Binge Drinking | 1 | 2023 | 45 | 0.200 |
Why?
| | Hawaii | 1 | 2023 | 34 | 0.200 |
Why?
| | Lung | 6 | 2025 | 4035 | 0.200 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 559 | 0.200 |
Why?
| | alpha-Defensins | 1 | 2022 | 10 | 0.200 |
Why?
| | Tryptophan | 1 | 2024 | 182 | 0.200 |
Why?
| | Cytotoxicity, Immunologic | 4 | 2013 | 222 | 0.190 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2022 | 47 | 0.180 |
Why?
| | Galectins | 2 | 2013 | 24 | 0.180 |
Why?
| | Delirium | 1 | 2023 | 89 | 0.180 |
Why?
| | Tight Junctions | 1 | 2021 | 77 | 0.180 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 109 | 0.170 |
Why?
| | Cell Cycle Proteins | 1 | 2024 | 614 | 0.170 |
Why?
| | Intestinal Mucosa | 3 | 2021 | 621 | 0.170 |
Why?
| | Astrocytes | 1 | 2022 | 210 | 0.170 |
Why?
| | Diet, High-Fat | 3 | 2020 | 248 | 0.160 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 115 | 0.160 |
Why?
| | Hepatitis C | 2 | 2016 | 272 | 0.160 |
Why?
| | Boston | 1 | 2020 | 92 | 0.160 |
Why?
| | Male | 18 | 2025 | 67385 | 0.160 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 64 | 0.160 |
Why?
| | Nuclear Proteins | 1 | 2024 | 705 | 0.160 |
Why?
| | Glomerulonephritis | 2 | 2018 | 47 | 0.160 |
Why?
| | Myocardium | 1 | 2024 | 895 | 0.160 |
Why?
| | Humans | 27 | 2025 | 136962 | 0.160 |
Why?
| | Cholesterol, Dietary | 1 | 2019 | 17 | 0.150 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 11 | 0.150 |
Why?
| | Perilipin-2 | 1 | 2019 | 41 | 0.150 |
Why?
| | Congresses as Topic | 1 | 2020 | 225 | 0.150 |
Why?
| | Osteopontin | 1 | 2018 | 32 | 0.140 |
Why?
| | Gastrointestinal Tract | 1 | 2020 | 202 | 0.140 |
Why?
| | Liver Diseases | 1 | 2021 | 300 | 0.140 |
Why?
| | Hepatocytes | 1 | 2019 | 217 | 0.140 |
Why?
| | Kidney Glomerulus | 1 | 2018 | 119 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1229 | 0.130 |
Why?
| | Myocardial Infarction | 1 | 2024 | 1046 | 0.130 |
Why?
| | Interleukin-10 | 2 | 2024 | 299 | 0.130 |
Why?
| | Sevelamer | 1 | 2016 | 9 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2016 | 203 | 0.130 |
Why?
| | Receptor, Adenosine A2A | 1 | 2016 | 20 | 0.130 |
Why?
| | Transcription Factors | 1 | 2024 | 1705 | 0.130 |
Why?
| | Adenosine A2 Receptor Agonists | 1 | 2016 | 21 | 0.130 |
Why?
| | Immunotherapy | 3 | 2017 | 627 | 0.130 |
Why?
| | Antigens, Neoplasm | 2 | 2010 | 316 | 0.130 |
Why?
| | Mice, Inbred BALB C | 4 | 2010 | 1256 | 0.120 |
Why?
| | Genomic Instability | 1 | 2016 | 53 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 759 | 0.120 |
Why?
| | Neoplasms | 2 | 2008 | 2698 | 0.120 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 2 | 2013 | 30 | 0.110 |
Why?
| | Fructokinases | 1 | 2013 | 32 | 0.100 |
Why?
| | Pregnancy | 2 | 2024 | 6736 | 0.100 |
Why?
| | Ligands | 3 | 2023 | 661 | 0.100 |
Why?
| | Mannose-Binding Lectins | 1 | 2013 | 11 | 0.100 |
Why?
| | Mice, Knockout | 5 | 2024 | 2999 | 0.100 |
Why?
| | Sucrose | 1 | 2013 | 110 | 0.100 |
Why?
| | Mice, Obese | 1 | 2013 | 66 | 0.100 |
Why?
| | Lectins, C-Type | 1 | 2013 | 64 | 0.100 |
Why?
| | Antibodies, Blocking | 2 | 2010 | 33 | 0.100 |
Why?
| | Female | 12 | 2025 | 73001 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 463 | 0.100 |
Why?
| | Biomarkers | 2 | 2024 | 4095 | 0.100 |
Why?
| | Interleukin-6 | 3 | 2025 | 781 | 0.100 |
Why?
| | Cyclic AMP | 1 | 2013 | 217 | 0.090 |
Why?
| | Chemokines | 2 | 2023 | 225 | 0.090 |
Why?
| | Macrophage Activation | 1 | 2013 | 199 | 0.090 |
Why?
| | Herpesviridae Infections | 1 | 2013 | 146 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 382 | 0.090 |
Why?
| | Receptors, Cell Surface | 1 | 2013 | 391 | 0.080 |
Why?
| | Conserved Sequence | 1 | 2011 | 235 | 0.080 |
Why?
| | Peptide Library | 2 | 2010 | 95 | 0.080 |
Why?
| | Aging | 3 | 2024 | 1849 | 0.080 |
Why?
| | Vaccines, Subunit | 1 | 2010 | 49 | 0.080 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2010 | 97 | 0.080 |
Why?
| | Killer Cells, Natural | 1 | 2013 | 448 | 0.080 |
Why?
| | Genome, Viral | 1 | 2011 | 220 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1085 | 0.070 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2010 | 248 | 0.070 |
Why?
| | Ischemia | 1 | 2011 | 407 | 0.070 |
Why?
| | Viral Proteins | 1 | 2011 | 359 | 0.070 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 415 | 0.070 |
Why?
| | Amino Acid Sequence | 3 | 2017 | 2139 | 0.070 |
Why?
| | Kidney | 2 | 2016 | 1466 | 0.070 |
Why?
| | Baculoviridae | 1 | 2008 | 44 | 0.070 |
Why?
| | Cloning, Molecular | 3 | 2004 | 534 | 0.070 |
Why?
| | H-2 Antigens | 1 | 2008 | 115 | 0.070 |
Why?
| | Up-Regulation | 1 | 2010 | 838 | 0.070 |
Why?
| | Insecta | 1 | 2008 | 70 | 0.070 |
Why?
| | Cross Reactions | 2 | 2017 | 130 | 0.060 |
Why?
| | Rats, Inbred Lew | 2 | 2003 | 113 | 0.060 |
Why?
| | Young Adult | 3 | 2025 | 13218 | 0.060 |
Why?
| | Genetic Variation | 1 | 2011 | 1000 | 0.060 |
Why?
| | Cathelicidins | 1 | 2025 | 41 | 0.060 |
Why?
| | Chemokine CXCL1 | 1 | 2025 | 76 | 0.060 |
Why?
| | Colonic Neoplasms | 1 | 2008 | 250 | 0.060 |
Why?
| | Immune Tolerance | 1 | 2008 | 363 | 0.060 |
Why?
| | Drug Design | 1 | 2006 | 165 | 0.060 |
Why?
| | Cholera Toxin | 1 | 2025 | 31 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 506 | 0.060 |
Why?
| | Obesity | 1 | 2019 | 3023 | 0.060 |
Why?
| | Haptoglobins | 1 | 2025 | 54 | 0.060 |
Why?
| | Bacteroidetes | 1 | 2024 | 24 | 0.060 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2024 | 23 | 0.060 |
Why?
| | Protein Precursors | 1 | 2025 | 133 | 0.050 |
Why?
| | Receptors, Interleukin-2 | 1 | 2004 | 65 | 0.050 |
Why?
| | Signal Transduction | 3 | 2024 | 5047 | 0.050 |
Why?
| | Ileum | 1 | 2024 | 109 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2011 | 802 | 0.050 |
Why?
| | Fatty Acids, Volatile | 1 | 2024 | 58 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2574 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2004 | 1343 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2010 | 2456 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2010 | 3556 | 0.050 |
Why?
| | Solubility | 1 | 2003 | 241 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 35 | 0.050 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2024 | 176 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2010 | 1083 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 47 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2024 | 4136 | 0.050 |
Why?
| | Occludin | 1 | 2021 | 11 | 0.050 |
Why?
| | Aged | 3 | 2023 | 23803 | 0.050 |
Why?
| | Fibroblasts | 2 | 2024 | 997 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2010 | 812 | 0.050 |
Why?
| | Molecular Sequence Data | 2 | 2003 | 2900 | 0.040 |
Why?
| | Autoimmunity | 1 | 2007 | 897 | 0.040 |
Why?
| | Malondialdehyde | 1 | 2021 | 29 | 0.040 |
Why?
| | Adult | 4 | 2025 | 37713 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2023 | 309 | 0.040 |
Why?
| | Colon | 1 | 2023 | 285 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2021 | 84 | 0.040 |
Why?
| | Cell Line | 3 | 2017 | 2855 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 676 | 0.040 |
Why?
| | Lipid Peroxidation | 1 | 2021 | 152 | 0.040 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 859 | 0.040 |
Why?
| | Intercellular Junctions | 1 | 2020 | 40 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 2021 | 150 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 29 | 0.040 |
Why?
| | Mice, Transgenic | 3 | 2011 | 2156 | 0.040 |
Why?
| | Streptococcus pneumoniae | 1 | 2022 | 167 | 0.040 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2001 | 68 | 0.040 |
Why?
| | Histocompatibility Antigens | 1 | 2001 | 106 | 0.040 |
Why?
| | Middle Aged | 3 | 2024 | 33225 | 0.040 |
Why?
| | Epitopes | 2 | 2017 | 476 | 0.040 |
Why?
| | Organ Specificity | 1 | 2020 | 305 | 0.040 |
Why?
| | Interferon-gamma | 3 | 2010 | 782 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2001 | 218 | 0.040 |
Why?
| | Glutathione | 1 | 2021 | 357 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2023 | 1484 | 0.040 |
Why?
| | Escherichia coli | 1 | 2003 | 823 | 0.040 |
Why?
| | Hepatitis | 1 | 2019 | 46 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7559 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 323 | 0.040 |
Why?
| | Gene Expression | 1 | 2003 | 1480 | 0.040 |
Why?
| | Urinary Tract | 1 | 2018 | 49 | 0.030 |
Why?
| | Isoantigens | 1 | 2017 | 16 | 0.030 |
Why?
| | Peptides | 2 | 2017 | 975 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 323 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 647 | 0.030 |
Why?
| | HLA-A2 Antigen | 1 | 2017 | 48 | 0.030 |
Why?
| | Molecular Mimicry | 1 | 2017 | 42 | 0.030 |
Why?
| | Rats | 2 | 2003 | 5544 | 0.030 |
Why?
| | Jurkat Cells | 1 | 2017 | 136 | 0.030 |
Why?
| | Hippocampus | 1 | 2022 | 897 | 0.030 |
Why?
| | Viral Nonstructural Proteins | 1 | 2017 | 67 | 0.030 |
Why?
| | Glomerular Basement Membrane | 1 | 2016 | 8 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 506 | 0.030 |
Why?
| | Bacteria | 1 | 2023 | 863 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 616 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3148 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1264 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1412 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2016 | 907 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2017 | 479 | 0.030 |
Why?
| | Protein Domains | 1 | 2017 | 289 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2019 | 522 | 0.030 |
Why?
| | Antigens, Viral | 1 | 2016 | 178 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1171 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 15535 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 727 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 642 | 0.030 |
Why?
| | Glucose | 1 | 2019 | 1029 | 0.030 |
Why?
| | Muromegalovirus | 1 | 2013 | 23 | 0.030 |
Why?
| | Fructose | 1 | 2013 | 112 | 0.020 |
Why?
| | Transcriptome | 1 | 2019 | 966 | 0.020 |
Why?
| | Receptors, Virus | 1 | 2013 | 93 | 0.020 |
Why?
| | Interleukin-15 | 1 | 2013 | 101 | 0.020 |
Why?
| | Interleukin-12 | 1 | 2013 | 120 | 0.020 |
Why?
| | Models, Molecular | 1 | 2017 | 1591 | 0.020 |
Why?
| | Entropy | 1 | 2011 | 40 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2708 | 0.020 |
Why?
| | Genes, Viral | 1 | 2011 | 90 | 0.020 |
Why?
| | Risk Factors | 1 | 2025 | 10363 | 0.020 |
Why?
| | Energy Intake | 1 | 2013 | 501 | 0.020 |
Why?
| | Nucleotides | 1 | 2011 | 125 | 0.020 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 13 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2019 | 1226 | 0.020 |
Why?
| | Spodoptera | 1 | 2010 | 40 | 0.020 |
Why?
| | Immunodominant Epitopes | 1 | 2010 | 27 | 0.020 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 81 | 0.020 |
Why?
| | Vaccination | 2 | 2010 | 1428 | 0.020 |
Why?
| | Weight Gain | 1 | 2013 | 535 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2010 | 140 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 198 | 0.020 |
Why?
| | Histocompatibility Antigen H-2D | 1 | 2008 | 21 | 0.020 |
Why?
| | Cross-Priming | 1 | 2008 | 16 | 0.020 |
Why?
| | CD11c Antigen | 1 | 2008 | 41 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2168 | 0.020 |
Why?
| | Amino Acids | 1 | 2011 | 493 | 0.020 |
Why?
| | RNA, Viral | 1 | 2011 | 682 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 561 | 0.020 |
Why?
| | Chronic Disease | 1 | 2011 | 1774 | 0.010 |
Why?
| | Silver Staining | 1 | 2004 | 17 | 0.010 |
Why?
| | Dendritic Cells | 1 | 2008 | 483 | 0.010 |
Why?
| | Genes, MHC Class II | 1 | 2004 | 75 | 0.010 |
Why?
| | Coculture Techniques | 1 | 2004 | 240 | 0.010 |
Why?
| | Cell Lineage | 1 | 2004 | 352 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3393 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 971 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 850 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2001 | 139 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 6786 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2004 | 1189 | 0.010 |
Why?
| | Transfection | 1 | 2001 | 934 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 21471 | 0.010 |
Why?
|
|
McMahan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|